SI-BONE, Inc. (SIBN)
NGM · Healthcare · Medical Devices
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About SI-BONE, Inc.
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 48.6M | 48.7M | 56.3M | 52.6M |
| Gross Profit | 38.8M | 38.8M | 44.5M | 41.9M |
| Operating Income | -7.0M | -5.4M | -2.5M | -5.1M |
| Net Income | -6.2M | -4.6M | -1.6M | -4.3M |
| Diluted EPS | $-0.14 | $-0.11 | $-0.04 | $-0.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 106.4M | 138.9M | 167.2M | 200.9M |
| Gross Profit | 90.7M | 109.4M | 132.1M | 159.9M |
| Operating Income | -59.6M | -46.9M | -35.2M | -22.3M |
| Net Income | -61.3M | -43.3M | -30.9M | -18.9M |
| Diluted EPS | $-1.79 | $-1.13 | $-0.75 | $-0.44 |